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Abstract: Recent trends in Ru complex chemistry are surveyed with emphasis on the 
development of anticancer drugs and applications in catalysis, polymers, materials science 
and nanotechnology. 
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1. Introduction 
Over the last couple of years, the field of coordination and organometallic chemistry of ruthenium 
has grown and evolved at unprecedented rates. Recent publications largely highlight key advances on  
Ru-based complexes and on their chemically addressable applications in challenging areas like 
biology, medicine, catalysis, nanoscience, redox and photoactive materials, etc. [1–5]. This explosive 
expansion is mainly due to the unique ability of the ruthenium core to permit multiple oxidation states, 
hence versatile electron-transfer pathways. 
Both Ru(II) and Ru(III) oxidation states accommodate six-coordinated octahedral configurations in 
which the additional axial ligands help fine-tune the steric and electronic properties of the complexes. 
Of consequence are also the relative weakness of certain metal-ligand bonds as well as the 
thermodynamic and kinetic stability of Ru(III)-complexes vs. Ru(II)-complexes since ligand exchange 
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kinetics are immediately affected [6]. Proper variations of ancillary ligands, allowing modulation of 
redox properties and ligand interactions, have resulted in a large platform of Ru complexes endowed 
with achiral or chiral configurations [7–14]. While older research takes new directions, cutting-edge 
applications have emerged in the already mentioned fields, yet also in materials science, 
petrochemistry, and oleochemistry. Further valorization of Ru complexes in photochemistry and 
photophysics, for pharmaceuticals and agrochemicals will undoubtedly be forthcoming. Admittedly, 
this brief overview cannot cover the huge diversity of recently introduced ruthenium complexes and 
concentrates essentially on concepts and trends disclosed during 2013–2014 and early 2015. A critical 
appraisal of these aspects is presented showcasing Ru-driven advances in anticancer chemotherapy, 
medicinal applications, catalysis, water oxidation, photoactive complexes, functional and nanomaterials 
and complex design that have newly taken center stage. 
2. Ruthenium-Based Anticancer Drugs. Medicinal Applications 
Though started over 50 years ago, the development of metal anticancer drugs has traditionally 
focused on cytotoxic platinum compounds, several of which have reached clinical application [15]. 
The deeper understanding of cancer biology triggered the introduction of targeted chemotherapies, 
using other metal-based drugs, able to address specific cancer physiologies or disease states [16–19]. 
As most of the ruthenium complexes are less toxic than their platinum counterparts, this progress 
offers considerable added value for medical implementation. Although so far none of the ruthenium 
complexes are in clinical use as anticancer drugs, the remarkable success in clinical trials of NAMI-A, 
KP1019, and KP1339, combined with abundant reports on the enhanced in vitro and in vivo activity of 
other types of ruthenium complexes, prompted ruthenium chemotherapeutics to rapidly become a 
major area in anticancer drug advancement [20–26]. In an illustrative example NAMI-A, inactive 
against primary tumors but specifically targeting tumor metastases, was shown to display an improved 
antimetastatic activity when turned into macromolecular NAMI-A, a biocompatible amphiphilic block 
copolymer forming micelles that increase the cytotoxicity and cell uptake of the drug [22]. In the 
search for superior metallodrugs, ruthenium chemistry is taking momentum through the introduction of 
Ru-containing macromolecular complexes (dendrimers, dendronized polymers, protein conjugates, 
intelligent nanoparticles for advanced drug delivery, and polymer Ru-complex conjugates) that better 
differentiate between tumor cells and healthy cells [26]. 
Currently considered among the most promising alternatives to platinum drugs, active by interaction 
with DNA, ruthenium complexes also operate via different mechanisms [27–33]. Both Ru(II) and 
Ru(III) oxidation states are stable in physiological solutions, with the latter considered to be less 
reactive; therefore, Ru complexes are generally reported to act as redox-activatable prodrugs [34,35]. 
Recent research largely illustrates that the in vitro and in vivo properties of ruthenium compounds can 
be finely tuned by ligand variation. Intense investigations converge on ligand selection from the arene, 
phosphine, aromatic heterocycles, pyridine, pta, pybox, pyrazolone-based β-ketoamine, nitrosyl, Schiff-base, 
carboxamide, carbothioamide, thiourea, thiocarbamate, thiosemicarbazone, and hydrazone classes [36–78]. 
Innovations were applied to construct coordination-driven self-assembled arene-Ru metalla-rectangles 
endowed with stronger cytotoxicity against all cancer cell lines and even more effective than 
established anticancer drugs like doxorubicin and cisplatin [50]. That interest in the bioactivity profiles 
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of ruthenium complexes has grown rapidly is amply demonstrated by design of new Ru compounds 
inhibiting enzymes, by the novel multinuclear systems acting as drug delivery vehicles or imaging and 
theranostics agents and signal transduction elements. A major contribution came as well from the 
advent of refined bioanalytical, biophysical and spectroscopic techniques used to elucidate the 
structure and the in vivo functioning of these complexes [79–100]. Some arene-functionalized 
dinuclear organometallic Ru(II) complexes are capable of crosslinking model peptide and 
oligonucleotide sequences while cytotoxicities are linked to their more rigid or more flexible 
conformations [81]. The mechanism of action of ruthenium-based antitumor drugs was studied, 
especially in regard to the capacity of ruthenium to mimic iron in its binding to biological molecules. 
Along these lines, new ruthenium complexes containing the enantiopure ligands 2,6-bis[4′(R)-
phenyloxazolin-2′-yl-pyridine] ((R,R)-Ph-pybox), 2,6-bis[4′(S)-isopropyloxazolin-2′-yl-pyridine] 
((S,S)-iPr-pybox) or 2,6-bis[4′(R)-isopropyloxazolin-2′-yl-pyridine] ((R,R)-iPr-pybox) and the water 
soluble 1,3,5-triaza-7-phosphaadamantane (PTA) or N-substituted PTA phosphanes, have been 
synthesized. Their interactions with plasmidic DNA and cytotoxic activities against human cervical 
cancer HeLa cell lines have been evaluated, evidencing the distinct ability of the enantiomeric ligands 
in affecting the cell cycle of HeLa tumor cells [101]. 
Incorporation of biologically-derived ligands that primarily aim at minimizing toxicity toward 
normal cells is a viable avenue for engineering ruthenium complexes since they provide ways to 
improve antiproliferative activity of metal-based drugs [102]. Such ligands display different 
coordination modes, facilitate compatibility of the complex with the biological environment, and 
promote a higher cellular uptake. The diversity of bio-relevant ligands installed as essential 
components of ruthenium complexes ranges from amino acids, peptides, proteins, carbohydrates, 
purine bases and oligonucleotides to steroids and other bioactive entities endowed with specific 
properties [103–108]. This methodology is confirmed by excellent studies on Ru complexes that open 
unique opportunities for rational design and production of potent ruthenium anticancer drugs tackling 
distinct transport pathways and mechanisms of action [108,109]. 
Photoactivation of ruthenium complexes for triggering and/or modulating their antitumor  
activity [110–113] is presently of great interest. The process enables transformation of unreactive 
Ru(II) complexes into light-driven cytotoxic species [114] that can subsequently interact with proteins 
and DNA at the cellular level. In some representative examples, it has been demonstrated that, using a 
clinical grade photodynamic therapy laser source, red-to-blue upconverting liposomes were capable of 
triggering photodissociation of ruthenium polypyridyl complexes from PEGylated liposomes [115]. 
Several ruthenium(II) polypyridyl complexes have been elaborated to act as two-photon absorption 
(TPA) agents in mitochondria-targeted photodynamic therapy, a promising new technique for 
resolving tumors selectively and subduing resistance to alternative anticancer therapies [116]. Cellular 
toxicity induced by photorelease of certain bioactive molecules has been proved as a valid alternative for 
Ru photodynamic therapeutic agents (PDT) with dual-action [117–119].  
When photoactivated, surface-grafted ruthenium complexes on mesoporous silica nanoparticles 
undergo photoexpulsion and subsequent release as cytotoxic entities toward cancer cells [120]. 
Nowadays, numerous accounts on photoactivatable Ru(II) complexes that exhibit different types of 
biologically relevant activities have been published [121–125]. Of real consequence for therapeutic 
purposes, catalytic reactions induced in cells by certain metallodrugs pertaining to the class of redox 
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modulators or photosensitizers may ensure low-dose therapy protocols [126]. An interesting catalytic 
procedure demonstrated that transfer hydrogenation promoted by Noyori-type ruthenium complexes 
can reduce coenzyme NAD+ to NADH in human ovarian cancer cells by using non-toxic 
concentrations of formate as a hydride donor source [127]. Such advanced catalytic processes enhance 
capabilities of ruthenium complexes, while also increasing selectivity towards cancer cells versus 
normal cells. 
Ruthenium complexes additionally find important medicinal applications as NO carriers and donors 
for induction of vascular relaxation (some Ru(III) complexes can act as nitric oxide scavengers thus 
improving graft survival). Drugs based on specific Ru complexes are active against parasitic diseases 
(e.g., leishmanicidal and protozoanicidal agents), as antibacterial, antifungal and anticorrosion 
additives in coatings on Ti-alloys used in medical devices [128–134]. 
3. Ruthenium Complexes in Catalysis 
Unquestionably, the second major area of overwhelming importance is catalysis promoted by Ru 
complexes, as also recognized by the Nobel Prizes awarded for the field. Productive catalytic applications 
of these complexes embrace a broad variety of chemical transformations, have known tremendous 
recent progress, while some are valorized on large scale, have true industrial perspectives or have already 
been industrialized [135]. Noteworthy, environmentally friendly homogeneous and immobilized ruthenium 
catalysts enabled indispensable synthetic methods inaccessible with other metal-based catalytic systems. 
With the aim of upgrading versatility of the ruthenium-based catalysis, new mononuclear, binuclear 
and polynuclear ruthenium complexes with arene, phosphine, phosphite, BINAP, alkylidene, 
vinylidene, allenylidene, indenylidene, N-heterocyclic carbene (NHC), cyclic alkyl amino carbene 
(CAAC), porphyrin, pincer, Schiff-base, polydentated and polycyclic ligands have continued to be 
prepared, minutely characterized and explored in chemoselective catalytic processes [136–158]. In an 
innovatory undertaking, graphene oxide was used to support ruthenium catalysts in order to activate 
self-healing in multifunctional materials that are able to simultaneously integrate the healing process 
with the advantageous properties of graphene-based materials [159]. Part of a large body of work 
concerns fundamental reactions studied anew with Ru complexes including hydrogenation and transfer 
hydrogenation; oxidation and hydroxylation; C–C, C–X and N–X bond formation; olefin metathesis and 
related C–C couplings; alkylation; arylation; isomerization; epimerization; condensation; cyclization; atom 
transfer radical reactions; oligomerization and polymerization [160–193]. Among non-metathetical 
reactions, the versatile and easy to handle transfer hydrogenation is often chosen as standard method 
for appraising and comparing the catalytic activity of ruthenium promoters [167–173]. 
In the chase for renewable energy sources currently in high demand, hydrogen resulting from 
electrochemical water splitting has been proposed as an energy carrier. Not long ago, an ingenuous 
method for hydrogen storage has been disclosed. The process, based on a CO2(HCO3−)/H2 and formate 
equilibrium within an amine-free reversible system is catalyzed by commercially available Ru pincer 
complexes and produces an advantageous mixture of H2 (CO free) and CO2 [194]. As a valuable 
addition to the multiple Ru-based catalyses, bond activations and functionalizations (e.g. H–H, C–H,  
N–H, O–H, B–H, and Si–H) have been explored [195–198]. 
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Stereoselective oxidative reactions of a host of functional groups, more specifically asymmetric 
epoxidation of alkenes, dihydroxylation of olefins, oxidative dehydrogenation of alcohols and generation 
of dioxygen species, have also been addressed using diverse ruthenium catalysts [199]. For example,  
a recent communication clearly evidenced that Ru–aqua complex {[RuII(trpy)(H2O)]2(μ-pyr-dc)}+can 
be a powerful epoxidation catalyst for a wide range of linear and cyclic alkenes [200]. 
A subject of renewed interest is presently the production of oxygen through water splitting by help 
of Ru catalysts as showcased in excellent reviews [201–203]. Mononuclear and binuclear ruthenium 
complexes have been explored in this reaction outlining the influence of monodentate and polydentate 
ligands on the course of water oxidation [204–212]. In the opposite process, water reduction, 
conducted with polydentated Ru catalysts, the solar H2 production was coupled to photoinitiated 
electron collection in polyazine chromophores [213]. 
One recent refined approach applies Ru(bpy)3Cl2 as photoredox catalyst and p-toluidine as redox 
mediator in the visible light photocatalytic thiol−ene “click” reaction for fast polymer  
post-functionalization and step-growth polymerization, under aerobic conditions [214]. 
Schiff-base (e.g. Salen) Ru-complexes enable versatile asymmetric catalysis for a range of chemical 
transformations, especially for carbene, nitrene, and oxene transfer reactions [11,146,215,216]. 
Complexes of this class reportedly serve as catalysts for oxidation/epoxidation, with chiral  
Ru-complexes such as Ru-porphyrin, desymmetric Ru-Schiff base and Ru-bisamide complexes being 
employed in asymmetric epoxidation. Importantly, (ON+)(Salen)ruthenium(II) complexes were found 
to catalyze epoxidation of conjugated olefins under light irradiation. In some instances, these olefins 
showed high enantioselectivity, greater than 80% ee, irrespective of their substitution pattern. 
Latterly, vast research centers on the functionalization of diverse organic substrates as promoted by 
ruthenium catalysts. For instance, alkynylation of aldehydes, hydroacylation, hydroboration and 
hydrosilylation of terminal alkynes, conjugate addition of alkynes to α,β-unsaturated carbonyl 
compounds, enantioselective carbonyl allylation, decarbonylation of acetone and carbonate, N-formylation 
of amines and reduction of hydrazine to ammonia (occurring with high chemoselectivity) have been 
tackled [198,217–224]. Racemization of sec-alcohols catalyzed by homogeneous half-sandwich 
ruthenium complexes (Cp*Ru(CO)2Cl) has been newly examined [225–227]; under the influence of 
the ruthenium catalyst, only the hydroxyl-substituted stereocenter was interconverted occasionally, 
making epimerization analogous to racemization. Computational investigations on CO dissociation 
within cyclopentadienyl ruthenium complexes, relevant to the racemization of alcohols, have been 
carried out as well [228]. For the 16- and 18-electron p-cymene ruthenium complexes, the ligand 
dissociation effect in racemization and dynamic kinetic resolution of alcohols was appraised [229].  
A cationic ruthenium complex for the efficient dynamic kinetic resolution of secondary alcohols has 
also been communicated [230]. 
With introduction of the new generations of highly active and chemoselective Ru metathesis 
catalysts endowed with high tolerance towards many functionalities and good stability in the presence 
of air, moisture and various solvents, including water-containing systems [231–239], the diversification 
of metathesis reactions experienced a strong impetus [240–245]. Among metathesis reactions,  
cross-metathesis (CM) [246–249] and ring-closing metathesis (RCM) [250–254] have become the 
most encountered strategies for the synthesis of linear and branched, or carbocyclic and heterocyclic 
compounds. Ru-catalyzed enyne metathesis (EYRCM) provided an elegant and productive way to 
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obtain small, medium and large cyclic molecules [255]. Numerous tandem metathesis protocols 
(RCM-CM, RCM-RCM, and RCM-ROM-CM), as well as related processes (C–C coupling, 
cyclopropanation, cyclizations, and polymerizations) facilitated the synthesis of complex organic 
molecules, intermediates for fine chemicals, bioactive natural products, macrocyclic or polycyclic 
structures, functional polymers and supramolecular architectures [256–264]. Intricate scaffolds for 
pharmaceuticals and agrochemicals have been accessed by these advanced strategies [265–267]. In a 
short time total syntheses, involving key metathesis steps (mostly RCM or EYRCM) were competitively 
advanced by different groups, providing an elegant and easier access to a plethora of complex bioactive 
molecules that display antitumor, antiviral, anti-HIV, antimicrobial, antifungal activities, and also to 
alkaloids and other classes of naturally occurring compounds [260,261,268]. More particular cases like 
metathesis-based syntheses of a range of iminosugars, and bioactive iriomoteolide and kendomycin were 
given special attention [269–273]. Synthesis, involving enyne metathesis, of biologically and medicinally 
significant molecules like (+)-anatoxin-A, (+)-anthramycin, artemisinin, transtaganolide D,  
allo-colchicine, (−)-galanthamine, (−)-longithorone A, (+)-ochromycinone, (+)-rubiginone B2, and  
(−)-stemoamide have become attractive when starting from adequate substrates [274]. It should be 
emphasized that cross-metathesis allowed diversification of synthetic strategies by employing substrates 
that are tolerated by the new generations of Ru complexes [231,236–239,243,244,246–249].  
A remarkably creative work encompasses the total synthesis of (−)-amphidinolide K and V applying 
an ingenious combination of Mo with Ru metathesis catalytic systems [275]. 
Ring-opening metathesis polymerization (ROMP) of monocyclic, bicyclic and polycyclic 
monomers with Ru complexes [276–279] unveiled polymerization methodologies capable to deliver 
unique materials not available by conventional polymerization techniques [280–285]. New types of 
telechelic and supramolecular polymers have been obtained by devising ruthenium catalysts suitable 
for their synthesis [286,287]. Ru complexes also intervene in acyclic diene metathesis polymerization  
(ADMET) [288,289] and polymerization of substituted acetylenes [290]. Not long ago, novel synthetic 
procedures based on ruthenium catalysis extended the range of biologically active polymers, 
biorenewable polymers and biodegradable copolymers [291–293]. 
Materials science took advantage of the contemporary capabilities of Ru complexes in inventive 
applications destined for industrial technologies. Thus, syntheses of nanoparticles and materials with 
nanostructured periodicity have been elaborated [294,295]. Polydicyclopentadiene (pDCPD) aerogels, 
obtained via ROMP, that are low-density nanostructured nanoporous solids with high surface-to-volume 
ratios, target applications including thermal and acoustic insulation, porous membranes, superhydrophobic 
surfaces and antireflection coatings [296]. Nanostructures based on gold-anchored ROMP polymers 
were introduced as valuable materials for microelectronics, catalysis and optophysics. 
With the purpose of enhancing the photovoltaic performance of solar cells, different research 
groups have attempted to modify the structure of the coordinated chromophoric and ancillary ligands 
of ruthenium-based dye sensitizers [297–300]. For example, though initially ruthenium(II) complexes 
used in luminescent applications such as dye-sensitized solar cells incorporated only poly-pyridine,  
poly-azolium or other poly-N-heterocyclic moieties, of late NHC substituents have also been added to 
give rise to the high energy emissions required for OLED devices [301]. In this new context, it has 
been shown that the free rotation in polypyridine ligands of Ru(II) complexes induces a substantial 
effect on the performance of light-emitting electrochemical cells [302]. Advanced research on the 
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electrochemical, photochromic, photovoltaic and redox properties of a variety of ruthenium complexes 
opens further perspectives of applications of ruthenium complexes, depending on their substitution 
pattern [303–305]. 
Sophisticated dendritic motifs have been made available for chemical sensors, electronic devices 
and catalytic reactions [306–309]. Multifunctional organometallic polymers obtained by ROMP in the 
presence of Mo and Ru complexes found interesting valorization in conducting materials and  
catalysis [310–313]. In a recent, very elegant work, it was demonstrated that mixed-valent “click” 
intertwined polymer units, containing biferrocenium chloride side chains, obtained by ROMP or 
radical chain reactions, form nanosnakes that encapsulate gold nanoparticles [314]. Worth notice is 
that polymers containing triazolylbiferrocenyl groups in the side or in the main chain, synthesized by 
ROMP, radical or “click” cycloaddition reactions, could be oxidized by [FeCp2][PF6], H[AuCl4], or 
Ag[BF4] to form stable triazolylbiferrocenium salts. Various Au and Ag nanoparticle networks were 
stabilized by these biferrocenium salts providing modified electrodes suitable for chemical sensing [315]. 
Elaborated bifunctional copolymers electrogenerated from pyrenebutyric acid, Nα′,Nα-bis(carboxymethyl)- 
L-lysine amide (NTA–pyrene) and, as a third component, the [tris-(2,2′-bipyridine)(4,4′-bis(4-pyrenyl-1- 
ylbutyloxy)-2,2′-bipyridine] ruthenium(II) hexafluorophosphate complex (Ru(II)–pyrene) allowed 
bioreceptor immobilization and transduction of biorecognition events. Such label-free 
photoelectrochemical immunosensors and aptasensors were applied to the determination of thrombin 
and the anti-cholera toxin antibody [316]. 
4. Ruthenium Complexes in Sustainable Processes 
This brief account could not be concluded without signaling at least a part of the newly acquired 
relevance of ruthenium complexes for industrial valorization [317–319]. As seen from this overview,  
Ru complexes contribute to sustainability through conservation of fossil resources and energy. Thus, 
oleochemisty by means of ruthenium catalysis, a field of major interest and presently intensively 
explored, is producing value-added synthetic products such as olefins, polymer additives, surface 
coatings, pharmaceuticals, etc. from natural seed oil feedstocks largely available in many countries. By 
a metathesis-based technology, palm oil and jojoba oil can be used to make high performance olefins 
and other specialty chemicals for a wide range of applications, including surfactants, detergents, 
lubricants, and biofuels [320,321]. A representative example of metathesis starting from renewable raw 
materials is self-metathesis of methyl oleate and cross-metathesis of methyl oleate with  
(Z)-2-butene-1,4-diol diacetate promoted by a series of indenylidene Ru catalysts [322]. A versatile 
ring-closing metathesis process has been developed for the synthesis of polyamide (nylon) precursors 
of various chain-lengths (PA11, 12, and 13); the technology allows an economical and sustainable 
production of these polymers from oleic acid as a single starting material [323]. Furthermore, a highly 
chemoselective procedure for obtaining valuable alcohols and higher-oxidation-state compounds by 
catalytic Z-selective cross-metathesis holds promise for a future application on a large scale [324]. In a 
patented procedure for valorization of biomass materials, cellulose was saccharified using a Ru catalyst 
supported on carbonized cellulose containing SO3H groups to give glucose in a 40% yield, at 68% 
cellulose conversion [325]. Cross-metathesis of bio-sourced fatty nitriles with acrylonitrile provides an 
efficient way for conservation of natural resources [326]. 
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Along quite different lines, alkenones, abundantly found in oceans, having chains of 37–39 carbon 
atoms, could be broken by olefin metathesis into 8–13 C-atom chains, thus becoming useful for jet  
fuel [327]. A newly disclosed invention employs Proxima (a thermoset resin for glass and carbon fiber 
reinforced composites, produced via olefin metathesis with Grubbs’ catalyst) to reduce the amount of 
carbon fiber required in hydrogen pressure vessels lowering in this way the cost of hydrogen storage 
tanks [328]. 
An important aspect in the industrial valorization of Ru complexes is the removal of ruthenium 
residues, mandatory in areas where the level of this heavy metal in the final products (pharmaceuticals, 
specialty polymers designed for food supplies, and biomedical, textile or electronic applications) could 
be problematic for human health [329]. Overall, the high potential and versatility of the Ru complexes 
attest to the importance they assume in chemistry and other scientific and technical areas and 
undoubtedly ensure the emergence, in the near future, of further developments serving mankind. 
The valuable contributions from the authors of this Special Issue “Ruthenium Complex” of 
Molecules are highly appreciated. Special thanks are due to the reviewers of the papers as well as to 
the members of the editorial staff of Molecules for their initiative for this Special Issue and their kind 
cooperation during the editorial process. We hope the readers will benefit from the diverse facets of the 
chemistry and applications of ruthenium complexes, included in this Special Issue, that largely 
illustrate the newest trends in the field. 
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